+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe In Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents), Technology (Coagulation, Molecular Diagnostics) By Application, End-use, Country, and Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 85 Pages
  • December 2023
  • Region: Europe
  • Grand View Research
  • ID: 5921033
Description Jump to:
The Europe in vitro diagnostics market size is expected to reach USD 28.10 billion by 2030, registering a CAGR of 0.7% during the forecast period. This expected increase in the demand is ascribed to the presence of novel and promising technologies in clinical laboratories, such as the introduction of Troponin T test by Roche Diagnostics in May, 2011.

Persistent research and development efforts made to introduce automation in laboratories that perform analytical testsare projected to propel the market growth over the forecast period. Clinical laboratory operations require automated analyzers to cope with the large test volumes,which enhance the overall operational workflow. It minimizes the need for dedicated operator training andnegates the risk of human errors. In addition, the rising demand for portable and handheld IVD devicesis one of the major factors pushing forward the growth of the market.

The increasing prevalence of chronic diseases, such as diabetes, cancers, and cardiac dysfunctions and the rising geriatric population coupled with the rising awareness towards early diagnosis in low-income countries, such as Bulgaria, Finland, Malta, and Estoniaare the potential drivers of the Europe IVD market.

Europe In Vitro Diagnostics Market Report Highlights

  • In 2022, the reagents segment dominated the Europe IVD market due to its increasing number of applications in the companion diagnostics area and the introduction of disease specific kits, such as the XpertTB kit
  • The IVD instruments market is anticipated to show lucrative growth due to the introduction of portable instruments, such as MinION Analyzer by Oxford Nanopore, and the availability of various platforms to performtarget sequence analysis, thereby driving the overall demand
  • UK is expected to be the fastest growing regionduring the forecast period.The rising demand for the point-of-care devices coupled with the government interventions to incorporate innovative, cost-effective solutions in the healthcare services are expected to drive the market growth during the forecast period.
  • The hospital-based IVD testing segment held the largest share. The highprocedure volumes in this segment, is one of the major reasons resulting inthehigh share and;hence, is anticipated to maintain its market position over the forecast period.
  • The presence of major IVD market players in Europe accelerates the penetration of the IVD products throughout the European Union. For instance, in September 2014, Roche Diagnostics launched the CE approved Cobas 6800/8800 systems, which offers IVD-based viral load monitoring withenhanced flexibility and automation.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Technology
1.1.3. Application
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Technology outlook
2.2.3. Application outlook
2.2.4. End use outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Europe In Vitro Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.2. Market restraint analysis
3.5. Europe In Vitro Diagnostics Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
Chapter 4. Europe In Vitro Diagnostics: Product Estimates & Trend Analysis
4.1. Europe In Vitro Diagnostics Market: Key Takeaways
4.2. Europe In Vitro Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Instruments
4.3.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Reagents
4.4.1. Reagents market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Services
4.5.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Europe In Vitro Diagnostics: Technology Estimates & Trend Analysis
5.1. Europe In Vitro Diagnostics Market: Key Takeaways
5.2. Europe In Vitro Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Immunology
5.3.1. Immunology market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Hematology
5.4.1. Hematology market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Clinical Chemistry
5.5.1. Clinical chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Molecular Diagnostics
5.6.1. Molecular diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Coagulation
5.7.1. Coagulation market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Microbiology
5.8.1. Microbiology market estimates and forecasts, 2018 to 2030 (USD Million)
5.9. Others
5.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Europe In Vitro Diagnostics: Application Estimates & Trend Analysis
6.1. Europe In Vitro Diagnostics Market: Key Takeaways
6.2. Europe In Vitro Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Infectious diseases
6.3.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Hormone Delivery
6.4.1. Hormone delivery market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Oncology/Cancer
6.5.1. Oncology/Cancer market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Cardiology
6.6.1. Cardiology market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Nephrology
6.7.1. Nephrology market estimates and forecasts, 2018 to 2030 (USD Million)
6.8. Autoimmune Diseases
6.8.1. Autoimmune diseases market estimates and forecasts, 2018 to 2030 (USD Million)
6.9. Drug Testing
6.9.1. Drug testing market estimates and forecasts, 2018 to 2030 (USD Million)
6.10. Others
6.10.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Europe In Vitro Diagnostics: End Use Estimates & Trend Analysis
7.1. Europe In Vitro Diagnostics Market: Key Takeaways
7.2. Europe In Vitro Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
7.3. Hospitals
7.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Laboratories
7.4.1. Laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Homecare
7.5.1. Homecare market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Others
7.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Europe In Vitro Diagnostics Market: Regional Estimates & Trend Analysis
8.1. Regional Outlook
8.2. Europe In Vitro Diagnostics Market by Region: Key Takeaways
8.3. Europe
8.3.1. UK
8.3.1.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.3.2. Germany
8.3.2.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.3.3. France
8.3.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.3.4. Italy
8.3.4.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.3.5. Spain
8.3.5.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.3.6. Sweden
8.3.6.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.3.7. Norway
8.3.7.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
8.3.8. Denmark
8.3.8.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.2.1. Bio-Rad Laboratories, Inc
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product benchmarking
9.2.1.4. Strategic initiatives
9.2.2. Abbott
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. Sysmex Corporation
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. BD
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. BIOMÉRIEUX
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Danaher
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. F. Hoffmann-La Roche Ltd
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
9.2.8. Siemens
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Product benchmarking
9.2.8.4. Strategic initiatives
9.2.9. QIAGEN
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Product benchmarking
9.2.9.4. Strategic initiatives
9.2.10. Thermo Fisher Scientific Inc
9.2.10.1. Company overview
9.2.10.2. Financial performance
9.2.10.3. Product benchmarking
9.2.10.4. Strategic initiatives
List of Tables
1. List of Abbreviation
2. Europe In Vitro Diagnostics Market, by Product, 2018-2030 (USD Million)
3. Europe In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Million)
4. Europe In Vitro Diagnostics Market, by Application, 2018-2030 (USD Million)
5. Europe In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Million)
6. Europe In Vitro Diagnostics Market, by Region, 2018-2030 (USD Million)
7. Germany In Vitro Diagnostics Market, by Product, 2018-2030 (USD Million)
8. Germany In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Million)
9. Germany In Vitro Diagnostics Market, by Application, 2018-2030 (USD Million)
10. Europe In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Million)
11. UK In Vitro Diagnostics Market, by Product, 2018-2030 (USD Million)
12. UK In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Million)
13. UK In Vitro Diagnostics Market, by Application, 2018-2030 (USD Million)
14.. UK In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Million)
15. France In Vitro Diagnostics Market, by Product, 2018-2030 (USD Million)
16. France In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Million)
17. France In Vitro Diagnostics Market, by Application, 2018-2030 (USD Million)
18. France In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Million)
19. Italy In Vitro Diagnostics Market, by Product, 2018-2030 (USD Million)
20. Italy In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Million)
21. Italy In Vitro Diagnostics Market, by Application, 2018-2030 (USD Million)
22. Italy In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Million)
23. Spain In Vitro Diagnostics Market, by Product, 2018-2030 (USD Million)
24. Spain In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Million)
25. Spain In Vitro Diagnostics Market, by Application, 2018-2030 (USD Million)
26. Spain In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Million)
27. Sweden In Vitro Diagnostics Market, by Product, 2018-2030 (USD Million)
28. Sweden In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Million)
29. Sweden In Vitro Diagnostics Market, by Application, 2018-2030 (USD Million)
30. Sweden In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Million)
31. Norway In Vitro Diagnostics Market, by Product, 2018-2030 (USD Million)
32. Norway In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Million)
33. Norway In Vitro Diagnostics Market, by Application, 2018-2030 (USD Million)
34. Norway In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Million)
35. Denmark In Vitro Diagnostics Market, by Product, 2018-2030 (USD Million)
36. Denmark In Vitro Diagnostics Market, by Technology, 2018-2030 (USD Million)
37. Denmark In Vitro Diagnostics Market, by Application, 2018-2030 (USD Million)
38. Denmark In Vitro Diagnostics Market, by End Use, 2018-2030 (USD Million)
List of Figures
1. Market research process
2. Data triangulation techniques
3. Primary research pattern
4. Market research approaches
5. Value-chain-based sizing & forecasting
6. QFD modeling for market share assessment
7. Market formulation & validation
8. Europe In Vitro Diagnostics: market outlook
9. Europe In Vitro Diagnostics competitive insights
10. Parent market outlook
11. Related/ancillary market outlook
12. Penetration and growth prospect mapping
13. Industry value chain analysis
14. Europe In Vitro Diagnostics market driver impact
15. Europe In Vitro Diagnostics market restraint impact
16. Europe In Vitro Diagnostics market strategic initiatives analysis
17. Europe In Vitro Diagnostics market: Product movement analysis
18. Europe In Vitro Diagnostics market: Product outlook and key takeaways
19. Instruments market estimates and forecasts, 2018-2030 (USD Million)
20. Reagents market estimates and forecasts, 2018-2030 (USD Million)
21. Services market estimates and forecasts, 2018-2030 (USD Million)
22. Europe In Vitro Diagnostics market: Technology movement analysis
23. Europe In Vitro Diagnostics market: Technology outlook and key takeaways
24. Immunology market estimates and forecasts, 2018-2030 (USD Million)
25. Hematology market estimates and forecasts, 2018-2030 (USD Million)
26. Clinical chemistry market estimates and forecasts, 2018-2030 (USD Million)
27. Molecular Diagnostics market estimates and forecasts, 2018-2030 (USD Million)
28. Coagulation market estimates and forecasts, 2018-2030 (USD Million)
29. Microbiology market estimates and forecasts, 2018-2030 (USD Million)
30. Other market estimates and forecasts, 2018-2030 (USD Million)
31. Europe In Vitro Diagnostics market: application movement analysis
32. Europe In Vitro Diagnostics market: application outlook and key takeaways
33. Infectious diseases market estimates and forecasts, 2018-2030 (USD Million)
34. Diabetes market estimates and forecasts, 2018-2030 (USD Million)
35. Oncology/Cancer market estimates and forecasts, 2018-2030 (USD Million)
36. Cardiology market estimates and forecasts, 2018-2030 (USD Million)
37. Nephrology market estimates and forecasts, 2018-2030 (USD Million)
38. Autoimmune diseases market estimates and forecasts, 2018-2030 (USD Million)
39. Drug Testing market estimates and forecasts, 2018-2030 (USD Million)
40. Others market estimates and forecasts, 2018-2030 (USD Million)
41. Europe in vitro diagnostics market: end use movement analysis
42. Europe in vitro diagnostics market: end use outlook and key takeaway
43. Hospitals market estimates and forecasts, 2018-2030 (USD Million)
44. Laboratories market estimates and forecasts, 2018-2030 (USD Million)
45. Home care market estimates and forecasts, 2018-2030 (USD Million)
46. Others market estimates and forecasts, 2018-2030 (USD Million)
47. Europe in vitro diagnostics market: end use outlook and key takeaways
48. Europe in vitro diagnostics market: regional movement analysis
49. Europe in vitro diagnostics market: regional outlook and key takeaways
50. Europe market estimates and forecasts, 2018-2030 (USD Million)
51. UK market estimates and forecasts, 2018-2030 (USD Million)
52. Germany market estimates and forecasts, 2018-2030 (USD Million)
53. France market estimates and forecasts, 2018-2030 (USD Million)
54. Italy market estimates and forecasts, 2018-2030 (USD Million)
55. Spain market estimates and forecasts, 2018-2030 (USD Million)
56. Sweden market estimates and forecasts, 2018-2030 (USD Million)
57. Norway market estimates and forecasts, 2018-2030 (USD Million)
58. Denmark market estimates and forecasts, 2018-2030 (USD Million)

Companies Mentioned

  • Bio-Rad Laboratories, Inc
  • Abbott
  • Sysmex Corporation
  • BD
  • BIOMÉRIEUX
  • Danaher
  • F. Hoffmann-La Roche Ltd
  • Siemens
  • QIAGEN
  • Thermo Fisher Scientific Inc

Methodology

Loading
LOADING...

Related Topics

Related Reports

In Vitro Diagnostics Market, Industry Trends and Global Forecasts to 2035: Distribution by Test Type, Type of Offering, Type of Technology, Therapeutic Area, End Users and Geographical Regions - Product Image

In Vitro Diagnostics Market, Industry Trends and Global Forecasts to 2035: Distribution by Test Type, Type of Offering, Type of Technology, Therapeutic Area, End Users and Geographical Regions

  • Report
  • 188 Pages
  • Global
From
U.S. In-Vitro Diagnostics Market - Focused Insights 2024-2029 - Product Image

U.S. In-Vitro Diagnostics Market - Focused Insights 2024-2029

  • Report
  • 115 Pages
  • United States
From
North America In-Vitro Diagnostics Market Forecast to 2030 - Regional Analysis - by Product & Services, Technology, Application, and End User - Product Image

North America In-Vitro Diagnostics Market Forecast to 2030 - Regional Analysis - by Product & Services, Technology, Application, and End User

  • Report
  • 112 Pages
  • North America
From
In-Vitro Diagnostics Market by Component, Technology, Specimen, Application, End User - Global Forecast 2025-2030 - Product Image

In-Vitro Diagnostics Market by Component, Technology, Specimen, Application, End User - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
IVD In Cardiology And Neurology Market Size, Share & Trends Analysis Report By Product Type (Instruments, Reagents & Consumables), By Technology, By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

IVD In Cardiology And Neurology Market Size, Share & Trends Analysis Report By Product Type (Instruments, Reagents & Consumables), By Technology, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 125 Pages
  • Global
From

About the In Vitro Diagnostics Market

In Vitro Diagnostics (IVD) is a medical technology used to diagnose diseases and conditions through the analysis of bodily fluids and tissues. It is used to detect, diagnose, and monitor diseases, as well as to assess the effectiveness of treatments. IVD tests are performed in laboratories, hospitals, and other healthcare settings. IVD tests are used to detect a wide range of conditions, including infections, genetic disorders, and cancer. They can also be used to monitor the progress of a disease or to assess the effectiveness of a treatment. IVD tests are used to detect and measure the presence of specific molecules, such as proteins, hormones, and enzymes, in a sample. IVD tests are performed using a variety of technologies, including immunoassays, molecular diagnostics, and flow cytometry. These tests are used to diagnose a wide range of conditions, including infectious diseases, genetic disorders, and cancer. Some of the major companies in the IVD market include Abbott Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.